WEEKEND UPDATE
 December 26, 2021
Dear Valued Reader,

Time for a break, dear friends -- this will be your last missive from your friendly neighborhood Gumshoe in 2021, as we close our offices down for the holiday week.  So... did you miss anything in the frenzied final week before Christmas?  Let's catch you up...

We started the week with a look at Dave Lashmet's "biggest drug in the world" pitch for a new anti-obesity pill... just click below for the Thinkolator answers on that one...


He found Apple at $1.49... Oracle at $0.51... Amazon at $46.

Marketwatch called him "The Advisor Who Recommended Google Before Anyone Else."

Now, investing legend Louis Navellier is revealing his Top 11 Stocks to Buy for 2022.

Click here to download your free copy.


Advertisement

And we also took a look at Jason Simpkins' tease about a "SpaceX Killer" that he calls the "IPO Opportunity of the Decade" ... my take on that one is here.

A story about Alex Green's "#1 5G Megastock" floated to the top of our requests pile, despite the fact that it's over two years old now... that's here, in case you were wondering.

Finally, to close out the year this week, I looked back the top teaser-stock performers of 2021, and the top performers from my Real Money Portfolio… along with some musings about the future and a few tidbits of news from our portfolio companies.  That's all in the last Friday File of 2021, which you'll find by clicking below...



Stock Gumshoe | travis@stockgumshoe.com | www.stockgumshoe.com
351 Pleasant St., Suite B #205, Northampton, MA 01060
Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice -- we can't tell you what you should do with your money, we can just share our opinions and perspective. Our authors try to use reliable information sources but also make mistakes of both fact and judgement on occasion, so all assertions should be checked and confirmed. You should speak with your financial advisor and understand everything fully before committing money to any investment.

Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe or the author. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.

Having trouble viewing this email? Read the web version.

You may unsubscribe if you no longer wish to receive our emails. We have no wish to email people who don't want to receive these messages. Please note that unsubscribing applies only to receiving emails, if you are a member of the Stock Gumshoe Irregulars that membership will not automatically change or be canceled. Please contact us if you need to change a paid membership.